ELIGIBILITY FOR POLYPILL THERAPY, SUBCLINICAL ATHEROSCLEROSIS, AND CARDIOVASCULAR EVENTS – NATIONAL IMPLICATIONS FOR THE APPROPRIATE USE OF PREVENTIVE PHARMACOTHERAPY: MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA)

✍ Scribed by Bittencourt, Marcio Sommer; Blaha, Michael; Blankstein, Ron; Vargas, Jose; Budoff, Matthew; Agatston, Arthur; Blumenthal, Roger; Nasir, Khurram

• Book ID: 122101186
• Publisher: Elsevier Science
• Year: 2013
• Tongue: English
• Weight: 344 KB
• Volume: 61
• Category: Article
• ISSN: 1558-3597
• DOI: 10.1016/S0735-1097(13)60813-X